Sarepta Therapeutics | Capital Ordinaire





Capital Ordinaire Changement Date
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amgen USD 539M 1000K 2025-12
BioCryst Pharmaceuticals USD 1.9M 3K 2023-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Capricor Therapeutics USD 46K 0 2025-03
Daiichi Sankyo JPY 1.85B 9K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 112K 11K 2023-09
Gilead Sciences USD 1.24B 1000K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Insmed USD 214.26M 1.67M 2025-12
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novavax USD 1.62M 211K 2024-09
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Tectonic Therapeutic USD 14.86M 111.83K 2024-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12


Sarepta Therapeutics Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.